Navigation Links
Nephros Reports 2012 Fourth Quarter and Full Year Financial Results
Date:3/4/2013

RIVER EDGE, N.J., March 4, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three months and full year ended December 31, 2012.

2012 Highlights

  • Increased ultrafiltration product revenues to approximately $1,010,000, an increase of 63% from prior year period
  • Received €750,000 license payment from Bellco S.r.l.
  • Received FDA clearance for on-line mid-dilution Hemodiafiltration (mid HDF)
  • Executed License and Supply Agreement with Medica S.p.A.
  • Director of U.S. Sales engaged
  • Permanent CEO engaged
  • Introduced full range of hospital filters
  • First Military orders shipped

"2012 was a productive year for Nephros.  With the FDA clearance of our on-line mid-dilution HDF system, the execution of our license and supply agreement with Medica, significant growth in our dialysis and hospital water filtration businesses, and our first military orders we believe we are establishing a solid foundation in our core markets in the U.S.," said John C. Houghton , President and Chief Executive Officer of Nephros.  "We will continue to build upon this foundation in the U.S. and look to expand our presence in Europe as we progress through 2013."

Financial Performance for the Year Ended December 31, 2012

Total revenues for the year ended December 31, 2012 were approximately $1,807,000 compared to approximately $2,214,000 for the year ended December 31, 2011.  Total revenues decreased approximately $407,000, or 18% as a result of decreases of approximately $733,000 related to our
'/>"/>

SOURCE Nephros, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Nephros Completes Bridge Financing
2. Nephros and Chem-Aqua Announce Distribution Agreement
3. Nephros Reports Third Quarter 2012 Financial Results
4. Nephros Reports Second Quarter 2012 Financial Results
5. Nephros Reports First Quarter 2012 Financial Results
6. Nephros Receives 510(k) Clearance for Hemodiafiltration System
7. Nephros Appoints John C. Houghton as President and Chief Executive Officer
8. ECRI Institute PSO Offers Key Reports on Health IT and Medication Safety for Patient Safety Awareness Week
9. Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
10. Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
11. IRIDEX Reports Record 2012 Fourth Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Texas , Nov. 21, 2014  World Hemp ... containing low THC, announces they are now offering legal, ... to Charlotte,s Web type strains grown in medical marijuana ... other neurological disorders, such as Parkinson,s, MS, and spinal ... US laws to pass, because imported CBD Oil Is ...
(Date:11/21/2014)... , 21. November 2014 /PRNewswire/ ... hat heute bekannt gegeben, dass die ... EMA) die Kennzeichnung als Orphan-Medizinprodukt an ... des Unternehmens zur Behandlung von Fibrodysplasia ... seltene, stark beeinträchtigende genetische Krankheit, die ...
(Date:11/21/2014)... Nov. 20, 2014  Market research firm Kalorama information says ... The Buy, in the medical device industry.  The firm ... will produce just 3% growth this year, which led ... of product lines and entrance by acquisition into new ... medical devices, The Global Market for Medical Devices, ...
Breaking Medicine Technology:New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... HONG KONG, Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ -- Golden ... - 801.HK; 910801.TW), China,s leading integrated healthcare enterprise, ... acquire the remaining interests in the Group,s Chinese ... HK$90 million in shares.  Upon completion of the ...
... Calif., Feb. 24, 2011 Amgen (Nasdaq: AMGN ... 3 head-to-head trial that compared XGEVA ™ (denosumab) to ... skeletal-related events (SREs) in 1,901 men with prostate cancer and ... met its primary and secondary endpoints and demonstrated XGEVA,s superiority ...
Cached Medicine Technology:Golden Meditech Acquires Remaining Stake in Chinese Herbal Medicine Business 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 3Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 4Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 5Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 6Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 7Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 8Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 9
(Date:11/22/2014)... NC (PRWEB) November 23, 2014 Cancer ... found a connection between intercellular communication tunnels and the ... read the full story on the Surviving Mesothelioma ... Center and the University of Minnesota have just released ... carry information and materials between cells. They found that ...
(Date:11/22/2014)... A classic black prom dress will never go ... suppliers, has unveiled its new items of black prom ... at a big discount, up to 70% off. People throughout ... new black prom dresses, made with the best materials, can ... of all customers, the company provides these beautiful outfits in ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding ... the business offers a wide range of special occasion ... allowing them to create multiple looks easily. , According ... collection of chic wedding dresses has been prepared for ... discounted rates now. Dylan Queen can always create what ...
(Date:11/22/2014)... Discount-Dress.com is an important company in the dress industry. ... company’s online market share by a series of promotions. Recently, ... announced a bridesmaid dress promotion for the new year 2015. ... the dresses from this company are not only of high ... very good at manufacturing wedding dresses. Customers prefer to choose ...
(Date:11/22/2014)... "My friend went in for a mammogram ... said an inventor from Cambria Heights, N.Y. "To add ... second time because the first results were inaccurate. Her ... patent-pending MAMO EASY to offer a more comfortable way ... patient from the pain normally involved with this procedure. ...
Breaking Medicine News(10 mins):Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2
... Storage and to Advance VSEL Research, NEW YORK, ... is pioneering the pre-disease collection, processing and long-term,storage of ... that,it has signed a collection center agreement with the ... Robin Smith, MD MBA, NeoStem,s Chairman and Chief Executive ...
... May 27 Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ... dollars from Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY ... the recently announced transaction,between Takeda Pharmaceutical Company Limited ... receive portions of future milestone and royalty,payments. This ...
... communities save time and money accepting automatic ... payments direct from resident bank accounts, PORTLAND, ... it,has added PaySimple, the leading provider of on-demand ... to help simplify resident billing,and collection for assisted ...
... join the Urban League of,Philadelphia for FREE Open House Clinics ... ages 19 and under, in,Pennsylvania,s Children,s Health Insurance Program (CHIP). ... the Urban League of Philadelphia, 121,S. Broad Street (between Chestnut ... Wednesday, May 28th, 6pm - 8pm Wednesday, ...
... at UCLA have identified a type of leukemia stem cell ... normal blood stem cells to become cancerous. , The discovery ... cells, attacking the disease at its very root and killing ... cells. The study appears in the May 22, 2008 issue ...
... Inc. (Nasdaq: EVVV ) today,announced that Robert Palmisano, ... the Goldman Sachs Twenty-Ninth Annual Global,Healthcare Conference on Tuesday, ... and 1:00 p.m. CT). The Goldman Sachs Twenty-Ninth Annual ... Niguel in,Dana Point, California., To access the webcast, ...
Cached Medicine News:Health News:NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital 2Health News:NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital 3Health News:Isis to Receive $4.6 Million From Alnylam 2Health News:Isis to Receive $4.6 Million From Alnylam 3Health News:Vigilan Offers PaySimple to Simplify Resident Billing and Collection 2Health News:Does Your Child Have Health Insurance? Urban League of Philadelphia Announces Free Open Houses for CHIP Enrollment 2Health News:UCLA researchers identify leukemia stem cells 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: